1. Home
  2. PEBO vs IOVA Comparison

PEBO vs IOVA Comparison

Compare PEBO & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peoples Bancorp Inc.

PEBO

Peoples Bancorp Inc.

HOLD

Current Price

$32.90

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.52

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEBO
IOVA
Founded
1902
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2005
2008

Fundamental Metrics

Financial Performance
Metric
PEBO
IOVA
Price
$32.90
$3.52
Analyst Decision
Buy
Buy
Analyst Count
5
10
Target Price
$33.50
$9.11
AVG Volume (30 Days)
190.0K
15.3M
Earning Date
04-21-2026
05-07-2026
Dividend Yield
5.05%
N/A
EPS Growth
N/A
14.84
EPS
2.99
N/A
Revenue
$197,000.00
N/A
Revenue This Year
$17.29
$51.55
Revenue Next Year
$2.97
$37.55
P/E Ratio
$10.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.21
$1.64
52 Week High
$34.33
$5.63

Technical Indicators

Market Signals
Indicator
PEBO
IOVA
Relative Strength Index (RSI) 58.62 46.12
Support Level $32.70 $2.02
Resistance Level $33.40 $4.34
Average True Range (ATR) 0.61 0.30
MACD 0.13 -0.12
Stochastic Oscillator 90.54 17.91

Price Performance

Historical Comparison
PEBO
IOVA

About PEBO Peoples Bancorp Inc.

Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: